INmune Bio Inc (INMB) earnings · $33.5M cap
These earnings events as JSON? API free 100/dayINmune Bio Inc (INMB) is a biotechnology company listed on US.
This INMB earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
When the next INMB 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 0.0% from 2025-06-30 to 2025-09-30. An earnings headline that ignores that move is noise.
Not investment advice. Full INMB research stays on the stock page; the tape stays on the quote page.
INMB earnings FAQ
What are INMB's latest revenue and net income?
Latest cached INmune Bio Inc (INMB) revenue for Sep 30, 2025 was $50.0K. Net income was -$6.5M. Statements: https://lician.com/financials/inmb
What is INMB's latest diluted EPS?
Latest cached INmune Bio Inc (INMB) diluted EPS for Sep 30, 2025 was -$0.24.
What period does the latest INMB earnings print cover?
The latest cached INmune Bio Inc (INMB) earnings print covers Sep 30, 2025. The prior cached period on this page is Jun 30, 2025.
How did INMB revenue change from the prior cached period?
Cached INmune Bio Inc (INMB) revenue was unchanged from $50.0K (Jun 30, 2025) to $50.0K (Sep 30, 2025). Statements: https://lician.com/financials/inmb
Where are INMB earnings listed?
Cached earnings facts for INmune Bio Inc (INMB) are listed at https://lician.com/earnings/inmb. Statements: https://lician.com/financials/inmb
Not investment advice.